Matches in SemOpenAlex for { <https://semopenalex.org/work/W3083458563> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3083458563 endingPage "102483" @default.
- W3083458563 startingPage "102483" @default.
- W3083458563 abstract "Background The objective of the study was to evaluate the indication, efficacy and safety of tocilizumab, a humanized anti–interleukin-6 receptor antibody, in patients with neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody associated diseases (MOGAD) encountered in current neurological practice. Material and Methods We conducted a retrospective analysis of an exhaustive cohort of patients with inflammatory CNS disorders at Toulouse University Hospital, France, from 2014 to 2020. Efficacy was evaluated with clinical outcome by the Annual Relapse Rate, and radiological outcome with MRI data. The other outcomes were adverse events and effectiveness according to the form of injection (intravenous or subcutaneous). Results Seven patients were treated with tocilizumab: four patients had NMOSD with AQP4+ antibodies (57%) and three had MOGAD (43%). Tocilizumab was administered in the presence of persistent clinical activity and/or severe side effects with other immunosuppressant medications. The median follow-up on tocilizumab was 23 months (4–50 months). All patients started with monthly intravenous injection, then three switched to a subcutaneous form. All patients were relapse-free throughout the duration of treatment with tocilizumab, and one presented with a new cervical lesion on MRI. Four patients had no adverse effect, two had a significant increase in infection rate, and one had dyslipidemia. Conclusion tocilizumab appears to be an effective therapy for patients with refractory NMOSD or MOGAD. Subcutaneous and intravenous injections appear to be equally effective." @default.
- W3083458563 created "2020-09-11" @default.
- W3083458563 creator A5014793571 @default.
- W3083458563 creator A5025519386 @default.
- W3083458563 creator A5036343171 @default.
- W3083458563 creator A5045540371 @default.
- W3083458563 creator A5085711179 @default.
- W3083458563 date "2020-11-01" @default.
- W3083458563 modified "2023-10-17" @default.
- W3083458563 title "Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series" @default.
- W3083458563 cites W1829342801 @default.
- W3083458563 cites W1991019975 @default.
- W3083458563 cites W2007147688 @default.
- W3083458563 cites W2100093402 @default.
- W3083458563 cites W2129229339 @default.
- W3083458563 cites W2625304812 @default.
- W3083458563 cites W2739545732 @default.
- W3083458563 cites W2800192720 @default.
- W3083458563 cites W2805049236 @default.
- W3083458563 cites W2901863094 @default.
- W3083458563 cites W2924068561 @default.
- W3083458563 cites W2991438804 @default.
- W3083458563 cites W3019956952 @default.
- W3083458563 cites W3044280054 @default.
- W3083458563 cites W4251248715 @default.
- W3083458563 doi "https://doi.org/10.1016/j.msard.2020.102483" @default.
- W3083458563 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32942119" @default.
- W3083458563 hasPublicationYear "2020" @default.
- W3083458563 type Work @default.
- W3083458563 sameAs 3083458563 @default.
- W3083458563 citedByCount "21" @default.
- W3083458563 countsByYear W30834585632020 @default.
- W3083458563 countsByYear W30834585632021 @default.
- W3083458563 countsByYear W30834585632022 @default.
- W3083458563 countsByYear W30834585632023 @default.
- W3083458563 crossrefType "journal-article" @default.
- W3083458563 hasAuthorship W3083458563A5014793571 @default.
- W3083458563 hasAuthorship W3083458563A5025519386 @default.
- W3083458563 hasAuthorship W3083458563A5036343171 @default.
- W3083458563 hasAuthorship W3083458563A5045540371 @default.
- W3083458563 hasAuthorship W3083458563A5085711179 @default.
- W3083458563 hasBestOaLocation W30834585631 @default.
- W3083458563 hasConcept C126322002 @default.
- W3083458563 hasConcept C141071460 @default.
- W3083458563 hasConcept C16005928 @default.
- W3083458563 hasConcept C197934379 @default.
- W3083458563 hasConcept C203014093 @default.
- W3083458563 hasConcept C2777178219 @default.
- W3083458563 hasConcept C2777185649 @default.
- W3083458563 hasConcept C2779134260 @default.
- W3083458563 hasConcept C2780640218 @default.
- W3083458563 hasConcept C2781137167 @default.
- W3083458563 hasConcept C71924100 @default.
- W3083458563 hasConceptScore W3083458563C126322002 @default.
- W3083458563 hasConceptScore W3083458563C141071460 @default.
- W3083458563 hasConceptScore W3083458563C16005928 @default.
- W3083458563 hasConceptScore W3083458563C197934379 @default.
- W3083458563 hasConceptScore W3083458563C203014093 @default.
- W3083458563 hasConceptScore W3083458563C2777178219 @default.
- W3083458563 hasConceptScore W3083458563C2777185649 @default.
- W3083458563 hasConceptScore W3083458563C2779134260 @default.
- W3083458563 hasConceptScore W3083458563C2780640218 @default.
- W3083458563 hasConceptScore W3083458563C2781137167 @default.
- W3083458563 hasConceptScore W3083458563C71924100 @default.
- W3083458563 hasLocation W30834585631 @default.
- W3083458563 hasLocation W30834585632 @default.
- W3083458563 hasLocation W30834585633 @default.
- W3083458563 hasOpenAccess W3083458563 @default.
- W3083458563 hasPrimaryLocation W30834585631 @default.
- W3083458563 hasRelatedWork W1977300079 @default.
- W3083458563 hasRelatedWork W2015486592 @default.
- W3083458563 hasRelatedWork W2374489749 @default.
- W3083458563 hasRelatedWork W2487755487 @default.
- W3083458563 hasRelatedWork W2731771972 @default.
- W3083458563 hasRelatedWork W2775071172 @default.
- W3083458563 hasRelatedWork W3122147892 @default.
- W3083458563 hasRelatedWork W3201701545 @default.
- W3083458563 hasRelatedWork W4249994924 @default.
- W3083458563 hasRelatedWork W4309164437 @default.
- W3083458563 hasVolume "46" @default.
- W3083458563 isParatext "false" @default.
- W3083458563 isRetracted "false" @default.
- W3083458563 magId "3083458563" @default.
- W3083458563 workType "article" @default.